Suppr超能文献

药物利用审查干预措施的评估:组胺拮抗剂的案例研究

Evaluation of a DUR intervention: a case study of histamine antagonists.

作者信息

Zimmerman D R, Collins T M, Lipowski E E, Sainfort F

机构信息

Center for Health Systems Research and Analysis, University of Wisconsin-Madison 53705.

出版信息

Inquiry. 1994 Spring;31(1):89-101.

PMID:7909535
Abstract

Drug Utilization Review (DUR) programs aim to control inappropriate prescribing and drug costs, but there are few rigorous studies of their impact. This paper presents the evaluation results of a DUR intervention (excessive duration of full-dose histamine-2 receptor antagonists) using a quasi-experimental design. We observe a greater reduction of H2RA use in the intervention group than in the comparison group, and a reduction in drug expenditures which exceeded the cost of targeting and notifying prescribers. The success of DUR programs depends on both their efficiency and the drug issues under consideration; the use of a comparison group is critical in the evaluation of their impact.

摘要

药物利用审查(DUR)项目旨在控制不适当的处方行为和药物成本,但对其影响进行严格研究的却很少。本文采用准实验设计,呈现了一项DUR干预措施(全剂量组胺-2受体拮抗剂使用时间过长)的评估结果。我们观察到,干预组中H2RA的使用减少幅度大于对照组,且药物支出有所减少,这一减少幅度超过了针对和通知开处方者的成本。DUR项目的成功取决于其效率以及所考虑的药物问题;在评估其影响时,使用对照组至关重要。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验